# Intranasal Ketamine Versus Intranasal Fentanyl

> **NCT04414800** · PHASE3 · COMPLETED · sponsor: **Isfahan University of Medical Sciences** · enrollment: 125 (actual)

## Conditions studied

- Multiple Trauma
- Pain, Acute

## Interventions

- **DRUG:** Placebo
- **DRUG:** Ketamine
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT04414800
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-01
- **Primary completion:** 2018-03-20
- **Final completion:** 2018-04-15
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04414800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04414800, "Intranasal Ketamine Versus Intranasal Fentanyl". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04414800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*